InsiderSignalSign in
← Insider buys

Jillian B. Thomsen has sold NKTR and made no open-market buys since Jan 2016

CFO at Nektar Therapeutics

SEC CIK 0001433457 · Filings on SEC.gov ↗

$0Bought
$10.9MSold
NoneLast buy

Every filing

32 filings since Jan 2016, newest first

NKTRSell

Nektar Therapeutics

CFO

$31K−3.0%Feb 17
NKTRSell

Nektar Therapeutics

CFO

$40K−3.0%Nov 18
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$26K−1.0%Feb 18
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$89K−4.0%Nov 17
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$184K−9.0%Aug 18
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$245K−8.0%May 19
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$262K−7.0%Feb 18
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$1.4M−30.0%Jan 29
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$203K−7.0%Nov 18
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$27K−1.0%Aug 19
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$31K−1.0%May 20
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$31K−1.0%Feb 20
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$854K−18.0%Feb 7
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$49K−2.0%Nov 20
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$33K−1.0%Aug 19
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$60K−1.0%May 17
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$77K−1.0%Feb 21
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$680K−9.0%Feb 6
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$154K−2.0%Nov 19
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$298K−5.0%May 18
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$1.4M−17.0%Apr 18
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$211K−4.0%Feb 20
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$51K−5.0%Aug 18
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$52K−5.0%May 18
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$2.2M−67.0%Mar 22
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$26K−3.0%Feb 17
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$28K−5.0%Nov 18
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$70K−8.0%Aug 17
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$1.5M−94.0%Jul 13
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$177K−74.0%Mar 11
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$172K−79.0%Feb 12
NKTRSell

Nektar Therapeutics

SVP and Chief Accounting Officer

$212K−79.0%Jan 21
About Jillian B. Thomsen

Jillian B. Thomsen is a Person and serves as Senior Vice President and Chief Financial Officer of Nektar Therapeutics, where she oversees accounting, financial reporting, FP&A, Sarbanes-Oxley compliance, treasury, tax, clinical outsourcing, and procurement functions.( She was promoted to CFO in July 2022 after serving as Senior Vice President, Finance and Chief Accounting Officer, and she joined Nektar in 2006.(

Thomsen has more than 30 years of finance and accounting experience.( Before Nektar, she was Deputy Controller of Calpine Corporation from 2002 to 2006, and she began her career in Arthur Andersen LLP’s audit and business advisory services practice, where she worked for 12 years.( She is a certified public accountant (inactive) and holds a Master of Accountancy from the University of Denver and a B.A. in Business Economics from Colorado College.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.